2025-02-01 2026-01-31 false No description of principal activity Capium Accounts Production 1.1 14587420 2025-02-01 2026-01-31 14587420 bus:AbridgedAccounts 2025-02-01 2026-01-31 14587420 bus:Micro-entities 2025-02-01 2026-01-31 14587420 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 14587420 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 14587420 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 14587420 2025-02-01 2026-01-31 14587420 2026-01-31 14587420 bus:RegisteredOffice 2025-02-01 2026-01-31 14587420 core:WithinOneYear 2026-01-31 14587420 core:AfterOneYear 2026-01-31 14587420 1 2025-02-01 2026-01-31 14587420 bus:Director1 2025-02-01 2026-01-31 14587420 bus:Director1 2026-01-31 14587420 bus:Director1 2024-02-01 2025-01-31 14587420 2024-02-01 14587420 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 14587420 2024-02-01 2025-01-31 14587420 2025-01-31 14587420 core:WithinOneYear 2025-01-31 14587420 core:AfterOneYear 2025-01-31 14587420 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 14587420 core:PlantMachinery 2025-02-01 2026-01-31 14587420 core:PlantMachinery 2026-01-31 14587420 core:PlantMachinery 2025-01-31 14587420 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-01-31 14587420 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 14587420 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 14587420 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 14587420 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 14587420 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 14587420 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 14587420 core:Non-currentFinancialInstruments 2026-01-31 14587420 core:Non-currentFinancialInstruments 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14587420
England and Wales
UYAI HEALTH LTD
Micro Entity
Period of accounts Start date: 01 February 2025 End date: 31 January 2026

UYAI HEALTH LTD Contents Page For the year ended 31 January 2026
Statement of Financial Position | 1

UYAI HEALTH LTD Statement of Financial Position As at 31 January 2026
|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | 1,198 |  |  | 1,782
Current assets |  | 40,937 |  |  | 28,557 |
Creditors: amount falling due within one year |  | (4,094) |  |  | (6,392) |
Net current assets |  |  | 36,843 |  |  | 22,165
Total assets less current liabilities |  |  | 38,041 |  |  | 23,947
Net assets |  |  | 38,041 |  |  | 23,947
Capital and reserves |  |  | 38,041 |  |  | 23,947
NOTES TO THE ACCOUNTS General Information UYAI HEALTH LTD is a private company, limited by shares, registered in England and Wales, registration number 14587420, registration address C/O ROKNOD ACCOUNTANTS LTD , OFFICE NO.1 CITY VIEW. 99 LONG STREET, MANCHESTER, M24 6UN. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2. | Tangible fixed assets
Cost or valuation | Plant and Machinery |  | Total
| £ |  | £
At 01 February 2025 | - |  | -
Additions | 2,650 |  | 2,650
Disposals | - |  | -
At 31 January 2026 | 2,650 |  | 2,650
Depreciation
At 01 February 2025 | 1,189 |  | 1,189
Charge for year | 263 |  | 263
On disposals | - |  | -
At 31 January 2026 | 1,452 |  | 1,452
Net book values
Closing balance as at 31 January 2026 | 1,198 |  | 1,198
Opening balance as at 01 February 2025 | 1,782 |  | 1,782
3. | Staff Costs
| 2026 |  | 2025
--- | --- | --- | ---
Average number of employees during the year | Number |  | Number
| 0 |  | 0
4. | Average number of employees Average number of employees during the year was 0 (2025 : 0).
For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts. The financial statements were approved by the director on 04 June 2026 and were signed by:
-------------------------------- Ekwere George UMOH Director
1